Complications and functional outcomes of high-risk patient with cardiovascular disease on antithrombotic medication treated with the 532-nm-laser photo-vaporization Greenlight XPS-180 W for benign prostate hyperplasia

[1]  GreenLight XPS for treating benign prostatic hyperplasia , 2017, BJU international.

[2]  H. Woo,et al.  Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180‐W Greenlight lithium triborate laser , 2017, BJU international.

[3]  Matthew P. Rutman,et al.  Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo‐Joules per gram of prostate? , 2016, BJU international.

[4]  S. Kaplan,et al.  Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation. , 2016, Urology.

[5]  F. Bruyère,et al.  A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. , 2016, European urology.

[6]  M. Oelke,et al.  EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. , 2015, European urology.

[7]  G. Mucciardi,et al.  Efficacy and safety of prostate vaporesection using a 120-W 2-μm continuous-wave Tm:YAG laser (RevoLix 2) in patients on continuous oral anticoagulant or antiplatelet therapy , 2013, International Urology and Nephrology.

[8]  U. Nagele,et al.  EAU guidelines on laser technologies. , 2012, European urology.

[9]  M. Remzi,et al.  Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. , 2012, European urology.

[10]  D. Liberman,et al.  GreenLight 180W XPS photovaporization of the prostate: how I do it. , 2011, The Canadian journal of urology.

[11]  S. Kaplan,et al.  Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. , 2011, The Journal of urology.

[12]  John T. Wei,et al.  Update on AUA guideline on the management of benign prostatic hyperplasia. , 2011, The Journal of urology.

[13]  U. Nagele,et al.  Guidelines on Lasers and Technologies , 2011 .

[14]  T. Gasser,et al.  Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. , 2007, European urology.

[15]  M. Elhilali,et al.  Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. , 2006, The Journal of urology.

[16]  F. Saad,et al.  Canadian guidelines for the management of benign prostatic hyperplasia. , 2005, The Canadian journal of urology.